Search:
Toggle Navigation
Search:
About Us
Our Company
Management Team
Board of Directors
Clinical Advisory Board
Investors
Contact Us
Product Candidates
Our Pipeline
Preclinical Candidates
Clinical Trials
Science
LANCE Precision Medicine Platform
Immuno
–
metabolic Pathways
Publications
News & Events
News
Events & Presentations
Careers
Why Landos?
Open Positions
News
1/04
Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis
Read More
7/14
Landos Biopharma Announces First Human Dosing in a Phase 1 Study of NX-13, its Novel Candidate for Inflammatory Bowel Disease
Read More
5/12
Landos Biopharma to Present at Two Upcoming Investor Conferences
Read More
3/24
Landos Biopharma to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference
Read More
2/26
Landos Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
Read More
1/09
Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference
Read More
1
2
3
…
6
Next »